Evidence map›Paper›PMID 35410605›Full record

ReviewCurrent neuropharmacology2023

The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease.

Angelika Chachaj, Kazimierz Gąsiorowski, Andrzej Szuba, Adrian Sieradzki, Jerzy Leszek

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06918145 (Clinical Study on the Safety, Efficacy, and Mechanisms of Lymphaticovenous Anastomosis), which is not on this map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06918145 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Clinical Study on the Safety, Efficacy, and Mechanisms of Lymphaticovenous Anastomosis (LVA) for the Treatment of Alzheimer's Disease (AD)

TypeinterventionalSponsorPeking University Third HospitalRan2025 to 2030Enrolled80ConditionsAlzheimer&Amp, #39, s Disease (AD)ArmsLymphaticovenous Anastomosis
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angelika ChachajDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, Poland.
Kazimierz GąsiorowskiDepartment of Basic Medical Sciences, Wroclaw Medical University, Wroclaw, Poland.
Andrzej SzubaDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, Poland.
Adrian SieradzkiDepartment of Nervous System Diseases, Wroclaw Medical University, Wroclaw, Poland.
Jerzy LeszekDepartment of Psychiatry, Wroclaw Medical University, Wroclaw, Poland.
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common cause of dementia worldwide. Pathological deposits of neurotoxic proteins within the brain, such as amyloid-ß and hyperphosphorylated tau tangles, are the prominent features in AD. According to recent studies, the newly discovered brain lymphatic system was demonstrated to be crucial in the clearance of metabolic macromolecules from the brain. Meningeal lymphatic vessels located in the dura mater drain the fluid, macromolecules, and immune cells from cerebrospinal fluid (CSF) and transport them, as lymph, to the deep cervical lymph nodes. The lymphatic system provides the perivascular exchange of CSF with interstitial fluid (ISF) and ensures the homeostasis of neuronal interstitial space. In this review, we aim to summarize recent findings on the role of the lymphatic system in AD pathophysiology and discuss possible therapeutic perspectives, targeting the lymphatic clearance mechanisms within the brain.

Indexed as

Alzheimer DiseaseGlymphatic SystemBrainExtracellular FluidHumansLymphatic Systemamyloid-β (Aβ)cerebrospinal fluid (CSF)Dementiaglymphatic systeminterstitial fluid (ISF)meningeal lymphatic vessels (MLVs)perivascular space

Identifiers

PMID35410605
PMCPMC10190136
OpenAlexW4223421273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.